Rare
lephants
Screener
Toggle theme
Cadre Holdings, Inc.
CDRE
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Total Cash from Operations:
$73.0M
Line Item
Value
% of Total
Other Financing
$0
0.0%
Working Capital
$7.8M
10.6%
Other
$64.9M
88.9%
Net Cash Flow
$353.0K
0.5%
Download CSV
